The Journal of pediatrics · 2025
Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive Study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Top Karina A, Bettinger Julie A, Embree Joanne E, Jadavji Taj, Purewal Rupeena, Sauvé Laura, Papenburg Jesse, Deeks Shelley L, Wilson Sarah E, Dahdah Nagib, Sadarangani Manish, Halperin Scott A, Kakkar Fatima, Morris Shaun K, IMPACT Investigators
Аннотация
OBJECTIVE: To compare characteristics of children assessed at Canadian Immunization Monitoring Program Active (IMPACT) centers for myocarditis, myopericarditis, and pericarditis according to COVID-19 vaccination status, and to evaluate the association with vaccination.
STUDY DESIGN: IMPACT conducted active surveillance for myocarditis, myopericarditis, and pericarditis by monitoring admission lists and diagnostic codes for children ≤16 years of age assessed in emergency departments or hospitalized with these conditions (June 2021 through December 2022). Clinical details and immunization histories were entered in an electronic database. Characteristics of cases meeting Brighton Collaboration case definitions for myocarditis and/or pericarditis were compared between COVID-19 mRNA vaccine-proximate (vaccination 0-21 days prior to presentation), remotely vaccinated (vaccinated >21 days prior), and unvaccinated cases. Relative incidence of myocarditis/myopericarditis/pericarditis 0-21 days after vaccination was estimated via a self-controlled case series analysis adjusted for pre-Omicron vs Omicron periods. Cell sizes <5 were suppressed.
RESULTS: Overall, 168 cases were included: 73 (43%) vaccine-proximate cases, 47 (28%) remotely vaccinated, 39 (23%) unvaccinated, and 9 (5%) with unknown vaccination status. Among vaccine-proximate cases, 88% (64/73) were male, and 95%-99% (69-72/73) were 12-16 years of age. Among unvaccinated cases, 56% (22/39) were male, and 36% (14/39) were 12-16 years of age. Unvaccinated cases appeared more likely to require intensive care unit care (28% vs <7% of vaccine-proximate cases). The adjusted relative incidence of myocarditis/myopericarditis/pericarditis 0-21 days postvaccination was 7.1 (95% CI 4.5-11.1).
CONCLUSIONS: Although myocarditis, myopericarditis, and pericarditis were associated with COVID-19 mRNA vaccination, children with postvaccine myocarditis, myopericarditis, and pericarditis appeared to have a less severe initial course than unvaccinated children.
STUDY DESIGN: IMPACT conducted active surveillance for myocarditis, myopericarditis, and pericarditis by monitoring admission lists and diagnostic codes for children ≤16 years of age assessed in emergency departments or hospitalized with these conditions (June 2021 through December 2022). Clinical details and immunization histories were entered in an electronic database. Characteristics of cases meeting Brighton Collaboration case definitions for myocarditis and/or pericarditis were compared between COVID-19 mRNA vaccine-proximate (vaccination 0-21 days prior to presentation), remotely vaccinated (vaccinated >21 days prior), and unvaccinated cases. Relative incidence of myocarditis/myopericarditis/pericarditis 0-21 days after vaccination was estimated via a self-controlled case series analysis adjusted for pre-Omicron vs Omicron periods. Cell sizes <5 were suppressed.
RESULTS: Overall, 168 cases were included: 73 (43%) vaccine-proximate cases, 47 (28%) remotely vaccinated, 39 (23%) unvaccinated, and 9 (5%) with unknown vaccination status. Among vaccine-proximate cases, 88% (64/73) were male, and 95%-99% (69-72/73) were 12-16 years of age. Among unvaccinated cases, 56% (22/39) were male, and 36% (14/39) were 12-16 years of age. Unvaccinated cases appeared more likely to require intensive care unit care (28% vs <7% of vaccine-proximate cases). The adjusted relative incidence of myocarditis/myopericarditis/pericarditis 0-21 days postvaccination was 7.1 (95% CI 4.5-11.1).
CONCLUSIONS: Although myocarditis, myopericarditis, and pericarditis were associated with COVID-19 mRNA vaccination, children with postvaccine myocarditis, myopericarditis, and pericarditis appeared to have a less severe initial course than unvaccinated children.